CNH Industrial Reports 59% Drop in 2025 Net Income, Details Impairments and New Antitrust Fine
CNH sits 35% above its 52-week low of $9.
Summary
CNH Industrial N.V. reported a significant 59% decline in 2025 net income and EPS, driven by lower sales volumes and substantial impairment charges, while also disclosing a new €57 million antitrust fine in Poland.
Key Events · Earnings and Guidance · CNH
-
Sharp Decline in 2025 Financial Performance
Net income attributable to CNH Industrial N.V. fell 59.1% to $510 million, and diluted EPS dropped 58.6% to $0.41, reflecting challenging market conditions and lower demand in agriculture and construction. Total revenues decreased by 8.8% to $18.095 billion.
-
Significant Impairment Charges Recorded
The company recorded $172 million in non-cash impairment charges related to in-process R&D from Raven and Bennamann acquisitions, and a $62 million impairment on investments in Monarch Tractors and other minority holdings. These charges contributed to higher R&D and 'Other, net' expenses.
-
New Antitrust Fine in Poland
The Polish Antitrust Authority issued a notification of decision imposing fines of approximately €57 million on CNH Polska and some of its dealers for alleged anticompetitive practices. The company disagrees with the allegations and filed an appeal on January 9, 2026.
-
Material Weakness in Internal Controls Remediation
CNH Industrial successfully remediated a previously reported material weakness in internal control over financial reporting related to the existence and completeness of raw material and work-in-process inventory as of December 31, 2025.
Analysis · CNH · Technology
The 10-K filing confirms a challenging 2025 for CNH Industrial, with a substantial decline in profitability across its core segments. The significant impairment charges highlight difficulties in integrating recent technology acquisitions and investments. The new antitrust fine in Poland introduces a material legal and financial risk, despite the company's intent to appeal. While the remediation of the material weakness in internal controls is a positive step for governance, and the ongoing share buyback demonstrates a commitment to shareholder returns, these are largely overshadowed by the poor financial results and new risks. Investors should monitor the ongoing market conditions, particularly in the agriculture sector, and the progress of the Polish antitrust appeal. The modification of executive compensation targets also warrants attention as it could impact executive incentives.
At the time of this filing, CNH was trading at $12.15 on NYSE in the Technology sector, with a market capitalization of approximately $15.1B. The 52-week trading range was $9.00 to $14.27. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.